Clearside raises $20M; Egalet nixes Shionogi deal;

@FierceBiotech: Pfizer is shuttering another U.K. R&D outpost, ditching 120 jobs. Article | Follow @FierceBiotech

@JohnCFierce: Lilly pulls the plug on a massive insulin project in a blow to its diabetes pipeline. Story | Follow @JohnCFierce

@DamianFierce: this is good SEO. Link | Follow @DamianFierce

> Clearside Biomedical closed a $20 million Series C financing to support its work on micro-injected treatments for back-of-the-eye diseases. News

> Novo Nordisk ($NVO) filed for European approval for a fast-acting version of its insulin NovoLog. More

> Egalet ($EGLT) terminated its collaboration with Shionogi, regaining the rights to a Phase I hydrocodone treatment designed to discourage abuse. Release

Medical Device News

@FierceMedDev: Dx Digest: Report | Follow @FierceMedDev

@VarunSaxena2: I've never seen a team invent so many ways to lose as the Detroit Lions! I knew it was coming! Unsure of call but it's the Lions after all. | Follow @VarunSaxena2

@EmilyWFierce: Google Life Sciences CMO opens up about research plans. Story | Follow @EmilyWFierce

> NIH funds a trio of robots to improve health, life quality for the disabled. Report

> Troubled Insulet recalling additional 18 lots of wearable insulin pump due to needle failure. More

Pharma News

@FiercePharma: #ICYMI yesterday: $TEVA to divest $1B in assets to clear antitrust hurdles to Allergan deal: Reuters. Story | Follow @FiercePharma

@CarlyHFierce: Lyxumia's CV results may help Sanofi's case for approval, but they won't score it points against SGLT2s. Story | Follow @CarlyHFierce

> If Pfizer's consumer health unit goes up for grabs, Reckitt's interested, CEO says. More

> Cancer drug prices vary across the globe as countries strike deals with Big Pharma: Study. Report

> Sun to launch copy of Novartis' best-selling drug Gleevec Feb. 1. Story

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID antibody intransally.

Forty percent of PK deficiency patients on mitapivat had hemoglobalin responses, compared to 0% in the placebo group.